Zero Upload Friction: Direct Clinical Blueprint for Your Specific Test Result
W
WholeBodyProtocol
Personalized for: 1.7 mg/dL · High

The High Creatinine Recovery Blueprint

A clinically engineered, 16-point recovery protocol tailored specifically for your 1.7 mg/dL reading. No report upload needed. Immediate instant access.

16 Tailored Clinical Modules Immediate First Steps Nutrition & Medication Guide Doctor Consultation Sheet
Live --+ blueprints prepared
Biomarker

Creatinine

Your Value

1.7 mg/dL

Profile

Not added

Symptoms

Not added

Blurred sample blueprint
Exhaustive Clinical Coverage

Everything Included in Your Personalized Blueprint

No generic advice or vague warnings. Each section is custom generated based on your exact Creatinine reading of 1.7 mg/dL.

1. Immediate First Steps

Specific actions to implement within the next 24 to 48 hours to halt progression.

2. What If You Ignore It

The 1-month, 3-month, 6-month, and 1-year progressive physiological risks.

3. Follow-Up Tests & Retest

Exact confirmatory tests & optimal retest timing.

4. Diet & Lifestyle Protocol

Foods to strictly eliminate, restorative superfoods, hydration volume, and exercise limits.

5. Doctor Visit Preparation

Word-for-word questions to ask your physician and exact clinical flags to raise.

6. Results & Severity Levels

Standard reference ranges explained and where your 1.7 mg/dL precisely sits.

7. Risk Level Matrix

Categorized risk classification.

8. Supplements & Meds Guide

Clinically researched compounds, exact dosages, and medications physicians evaluate.

9. Medication Warnings

Common OTC pain meds (NSAIDs like ibuprofen) and prescriptions that dangerously elevate levels.

10. Recovery Timeline

Expected physiological recovery milestones across 2 weeks, 1 month, 3 months, and 6 months.

11. Red Flags & Emergencies

Clear symptoms separating what is routine from what warrants an immediate ER visit.

12. Symptom Progress Tracker

Weekly structured scorecards to log fatigue, physical recovery, and biomarker normalization.

13. Common Worries & Answers

Direct answers to the top anxieties patients face after seeing a 1.7 mg/dL result.

14. Underlying Causes Checklist

Comprehensive investigation of primary, secondary, and overlooked environmental root causes.

15. When Lifestyle Isn't Enough

Clinical triggers where medical therapeutics and specialist interventions become mandatory.

16. Long-Term Prevention

Maintenance lifestyle protocols to permanently keep your markers in the optimal zone.

INSTANT CLINICAL BLUEPRINT

Get Your Custom Recovery Blueprint

Formulated for: Creatinine (1.7 mg/dL)

16-Point Recovery Blueprint $69.00
Total Due Today: $19.00

One-time payment · Instant generation · No subscription

Blueprint Calibration Details Test & Value Locked
Editable
Editable

Our clinical analysis system will cross-reference your specific medications against Creatinine to check for drug-induced influences.

Analysis Time ~ 2 Minutes: Your personalized 16-point blueprint is typically generated on your screen within 2 minutes, with options to download or print it.
256-Bit SSL Encryption
liver
kidney
cholesterol
blood
vitamin
inflammation
sugar
overall
thyroid
anemia
Inside your recovery blueprint

Not a range printout. A written plan.

Mapped to your numbers, your symptoms, and your medications.

Severity map

Which markers are mildly abnormal vs severely dangerous.

Follow-up tests

Which tests you actually need, why, and when.

Diet protocol

Foods to eat and foods to avoid for your specific results.

Retest timeline

Exactly when to repeat each test to track progress.

Medications that help

What may bring your abnormal results back toward normal.

Medications to avoid

Critical list of drugs to avoid with your specific markers.

Home remedies

Natural steps you can start today.

Doctor visit prep

The critical questions most patients forget to ask.

Clinical pattern recognition

The patterns a reference range quietly misses

A lab flags each value as high or low on its own. Clinical medicine doesn't work that way. Your analysis reads markers together, as ratios, indices and organ-system patterns, the same way a specialist reads a chart.

How findings are classified
Red flag Needs prompt clinical follow-up
Early signal Subclinical drift inside "normal"
Differentiate Two causes, one result: tells them apart
Stage Risk graded by clinical guideline
i.
Reference-interval positioning

Where each value sits inside its range, because a ferritin of 18 and one of 180 are both "normal" but mean very different things.

ii.
Inter-marker ratios & indices

Validated clinical calculations such as AST/ALT, BUN/creatinine, TG/HDL and FIB-4, which no single marker can show.

iii.
Organ-system pattern mapping

Markers grouped by physiology (hepatic, renal, hematologic, endocrine) to separate a true pattern from an isolated blip.

iv.
Clinical correlation

Results weighed against your age, symptoms and medications, including drug-induced and assay-interference effects.

De Ritis AST : ALT ratio FIB-4 Liver fibrosis index HOMA-IR Insulin resistance Mentzer MCV : RBC index CKD-EPI 2021 eGFR BUN : Cr Pre-renal vs renal TG : HDL Atherogenic ratio NLR Neutrophil-lymphocyte ratio TSAT Transferrin saturation Anion gap Acid-base status Corrected Ca Albumin-adjusted calcium Non-HDL-C Remnant cholesterol
HematologyPanel 01

Erythropoiesis & Iron Kinetics

Red cell production, iron stores and transport
HbHctRBCMCVMCHRDWFerritinTSATTIBC
Low ferritin with normal hemoglobin
Early signal
Iron-depleted erythropoiesis, latent iron deficiency before anemia appears.
Microcytosis with raised RDW
Differentiate
Anisocytosis: iron deficiency vs thalassemia trait, separated using the Mentzer index.
High ferritin with high TSAT
Red flag
Possible iron overload, prompting HFE hemochromatosis screening.
Differentials weighedIron-deficiency anemia · anemia of chronic disease · β-thalassemia trait · B12/folate macrocytosis
HepatologyPanel 02

Hepatocellular & Cholestatic Function

Liver cell injury, bile flow and synthetic capacity
ALTASTGGTALPBilirubinAlbuminPlatelets
ALT > AST with raised triglycerides and glucose
Early signal
Pattern consistent with MASLD (metabolic dysfunction-associated steatotic liver disease).
ALP rise, with or without GGT
Differentiate
Cholestatic (biliary) vs osseous (bone) source of alkaline phosphatase.
FIB-4 score from age, AST, ALT and platelets
Stage
Non-invasive stratification of advanced liver fibrosis risk.
Differentials weighedSteatotic liver disease · alcohol-related injury · drug-induced liver injury · Gilbert's syndrome
NephrologyPanel 03

Glomerular Filtration & Renal Reserve

Filtration rate, nitrogen balance and urate handling
CreatinineeGFRBUNCystatin CUric acidUACR
BUN : creatinine ratio above 20
Differentiate
Pre-renal azotemia (dehydration, high protein) vs intrinsic kidney disease.
eGFR below 90 with albuminuria
Stage
Chronic kidney disease graded on KDIGO G and A categories.
"Normal" creatinine with low muscle mass
Early signal
Creatinine can overstate kidney function, so cystatin C confirmation is considered.
Differentials weighedVolume depletion · early CKD · NSAID nephrotoxicity · hyperuricemia
MetabolicPanel 04

Glycemic Control & Insulin Sensitivity

Glucose regulation and beta-cell compensation
Fasting glucoseHbA1cFasting insulinHOMA-IRC-peptide
Normal glucose with raised fasting insulin
Early signal
Compensated insulin resistance, often years before glucose rises.
HbA1c 5.7–6.4%
Stage
Prediabetes by ADA criteria, read alongside fasting glucose.
HbA1c out of step with glucose
Differentiate
Red-cell turnover (anemia, hemoglobinopathy) can falsely shift HbA1c.
Differentials weighedInsulin resistance · prediabetes · PCOS-related IR · statin-associated glucose rise
CardiologyPanel 05

Atherogenic Lipid Profile

Lipoprotein burden and cardiovascular risk
LDL-CHDL-CTGNon-HDL-CApoBLp(a)hs-CRP
Normal LDL-C with high ApoB
Red flag
Discordance: particle number, not cholesterol content, drives risk.
TG : HDL ratio elevated
Early signal
Surrogate for small, dense LDL and underlying insulin resistance.
Elevated Lp(a)
Stage
Inherited risk enhancer, largely unaffected by diet.
Differentials weighedAtherogenic dyslipidemia · familial hypercholesterolemia · secondary dyslipidemia (thyroid, renal)
EndocrinologyPanel 06

Hypothalamic–Pituitary–Thyroid Axis

Hormone output, conversion and autoimmunity
TSHFree T4Free T3TPO-AbTg-AbReverse T3
High-normal TSH with positive TPO antibodies
Early signal
Early autoimmune (Hashimoto's) thyroiditis while hormones still look normal.
Low TSH with low Free T4
Red flag
Central (secondary) hypothyroidism, pointing to the pituitary, not the thyroid.
Results that don't fit the clinical picture
Differentiate
Assay interference, such as high-dose biotin, vs true thyroid disease.
Differentials weighedSubclinical hypothyroidism · Hashimoto's · non-thyroidal illness · biotin interference
Nutrition & BonePanel 07

Micronutrients & Mineral Metabolism

Methylation, calcium–PTH–vitamin D balance
B12MMAHomocysteineFolate25-OH Vit DCaPTHMg
Low-normal B12 with raised MMA or homocysteine
Early signal
Functional B12 deficiency at the tissue level despite a "normal" serum B12.
Low vitamin D with raised PTH
Differentiate
Secondary hyperparathyroidism, a compensatory response affecting bone.
High calcium with non-suppressed PTH
Red flag
Primary hyperparathyroidism screen with albumin-corrected calcium.
Differentials weighedPernicious anemia · PPI/metformin depletion · osteomalacia · parathyroid adenoma
ImmunologyPanel 08

Systemic Inflammation & Immune Response

Acute-phase reactants and leukocyte profile
CRPhs-CRPESRWBC diffNLRFerritinANA
CRP and ESR moving apart
Differentiate
Acute inflammation vs chronic or protein-driven causes of a high ESR.
Persistently raised hs-CRP
Early signal
Low-grade chronic inflammation, a recognised cardiovascular risk enhancer.
High ferritin with high CRP
Differentiate
Ferritin acting as an acute-phase reactant, not true iron excess.
Differentials weighedOccult infection · autoimmune disease · inflammatory bowel disease · metabolic inflammation
Internal MedicinePanel 09

Electrolytes & Acid–Base Balance

Fluid, sodium–potassium and bicarbonate status
NaKClHCO₃Anion gapAlbumin
Calculated anion gap
Differentiate
Classifies metabolic acidosis as high-gap or normal-gap.
Low potassium with high-normal sodium
Red flag
Possible mineralocorticoid excess, screened with an aldosterone–renin ratio.
Borderline-high potassium on ACE-i or ARB
Early signal
Drug-associated hyperkalemia risk, especially with reduced eGFR.
Differentials weighedPrimary aldosteronism · diuretic effect · renal tubular acidosis · pseudohyperkalemia
Reproductive EndocrinologyPanel 10

Adrenal & Gonadal Axis

Sex hormones, binding proteins and stress hormones
Total TFree TSHBGEstradiolLHFSHProlactinCortisol
Normal total testosterone with high SHBG
Early signal
Low free (bioavailable) testosterone hidden behind a normal total.
Low testosterone with low or normal LH
Differentiate
Secondary (pituitary) vs primary (testicular) hypogonadism.
Raised androgens with LH-dominant ratio
Stage
Biochemical PCOS phenotype, read with metabolic markers.
Differentials weighedHypogonadism · PCOS · hyperprolactinemia · cortisol excess
HematologyPanel 11

Blood Cell Lines & Marrow Signals

White cells, platelets and red-cell mass together
WBCNeutrophilsLymphocytesPlateletsMPVHct
Persistently high hematocrit
Red flag
Secondary erythrocytosis (sleep apnea, smoking) vs JAK2-driven polycythemia.
More than one cell line abnormal
Red flag
Changes across white cells, red cells and platelets suggest a marrow-level process.
Neutrophil–lymphocyte ratio
Differentiate
Bacterial vs viral picture and physiological stress response.
Differentials weighedObstructive sleep apnea · myeloproliferative neoplasm · reactive thrombocytosis · viral suppression
Clinical PharmacologyPanel 12

Drug–Laboratory Interactions

Medications that change what your results mean
StatinsMetforminPPIsNSAIDsACE-i / ARBBiotin
Long-term metformin or PPI use
Early signal
Recognised depletion of B12 and magnesium over time.
Regular NSAIDs with falling eGFR
Red flag
Drug-associated decline in kidney filtration.
Statin with rising ALT or HbA1c
Differentiate
Expected drug effect vs a new underlying problem.
Differentials weighedDrug-induced change · supplement interference · true disease progression
12 organ-system panels Validated clinical indices Guideline-referenced staging (ADA, KDIGO) Medication-aware interpretation

What patients say

Notes from people who wanted a clearer reading of their results.

—★★★★★